Metabolic Research Compound

Retatrutide

Triple GIP/GLP-1/Glucagon Receptor Agonist — 8mg lyophilized powder. Analytical-grade research standard.

✓ 99% Purity✓ HPLC Verified✓ COA Included✓ Canada-Wide

Compound Specifications

Compound

Retatrutide

Amount

8mg

Purity

≥99% HPLC

Form

Lyophilized Powder

Lot

VT-R01

Storage

−20°C long-term

Ships From

Canada

Availability

In Stock

$200.00 CAD

● In Stock — Ships within 1–2 business days

Order via WhatsApp → Order via Email

⚠ For research purposes only. Not for human consumption. Must be 19+ to purchase.

Overview

What is Retatrutide?

Retatrutide is a next-generation triple agonist acting on GIP, GLP-1, and glucagon receptors simultaneously. It represents an advanced analytical reference compound for researchers studying multi-receptor metabolic pathway interactions.

VELTRIDE supplies Retatrutide at ≥99% HPLC purity with a Certificate of Analysis available for every lot, shipped discreetly Canada-wide.

Research Areas

Key Research Applications

Triple GIP/GLP-1/glucagon receptor co-activation studies
Multi-receptor agonism and downstream signaling pathway research
Advanced metabolic pathway modeling and analysis
Comparative pharmacodynamic studies with mono and dual agonists
Hepatic glucose production regulation research
Energy expenditure and metabolic rate studies in animal models
Next-generation receptor agonist characterization

Related Compounds

Frequently Studied With

⚠ Research Use Only Disclaimer All VELTRIDE products are strictly for in-vitro laboratory and analytical research purposes only. Not for human consumption, veterinary use, or medical treatment. Not approved by Health Canada for therapeutic use. By purchasing, you confirm you are 19+ and a qualified researcher using these compounds in a controlled research setting.